On Monday, Karyopharm Therapeutics Inc (NASDAQ: KPTI) opened higher 6.30% from the last session, before settling in for the closing price of $0.78. Price fluctuations for KPTI have ranged from $0.58 to $1.95 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 56.57% over the last five years. Company’s average yearly earnings per share was noted 43.09% at the time writing. With a float of $115.36 million, this company’s outstanding shares have now reached $125.30 million.
The firm has a total of 325 workers. Let’s measure their productivity. In terms of profitability, gross margin is 95.68%, operating margin of -84.86%, and the pretax margin is -58.73%.
Karyopharm Therapeutics Inc (KPTI) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Karyopharm Therapeutics Inc is 8.58%, while institutional ownership is 47.15%. The most recent insider transaction that took place on Dec 04 ’24, was worth 2,932. In this transaction President and CEO of this company sold 3,620 shares at a rate of $0.81, taking the stock ownership to the 1,128,312 shares. Before that another transaction happened on Nov 05 ’24, when Company’s President and CEO sold 3,675 for $0.91, making the entire transaction worth $3,346. This insider now owns 1,131,932 shares in total.
Karyopharm Therapeutics Inc (KPTI) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 43.09% per share during the next fiscal year.
Karyopharm Therapeutics Inc (NASDAQ: KPTI) Trading Performance Indicators
Check out the current performance indicators for Karyopharm Therapeutics Inc (KPTI). In the past quarter, the stock posted a quick ratio of 2.93. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.68.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.14, a number that is poised to hit -0.25 in the next quarter and is forecasted to reach -0.71 in one year’s time.
Technical Analysis of Karyopharm Therapeutics Inc (KPTI)
Analysing the last 5-days average volume posted by the [Karyopharm Therapeutics Inc, KPTI], we can find that recorded value of 1.43 million was lower than the volume posted last year of 1.56 million. As of the previous 9 days, the stock’s Stochastic %D was 92.07%. Additionally, its Average True Range was 0.06.
During the past 100 days, Karyopharm Therapeutics Inc’s (KPTI) raw stochastic average was set at 45.18%, which indicates a significant decrease from 99.60% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 109.50% in the past 14 days, which was higher than the 79.05% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.7901, while its 200-day Moving Average is $0.9256. Now, the first resistance to watch is $0.8493. This is followed by the second major resistance level at $0.8697. The third major resistance level sits at $0.9093. If the price goes on to break the first support level at $0.7893, it is likely to go to the next support level at $0.7497. Now, if the price goes above the second support level, the third support stands at $0.7293.
Karyopharm Therapeutics Inc (NASDAQ: KPTI) Key Stats
There are currently 126,191K shares outstanding in the company with a market cap of 100.53 million. Presently, the company’s annual sales total 146,030 K according to its annual income of -143,100 K. Last quarter, the company’s sales amounted to 38,780 K and its income totaled -32,070 K.
